• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体α通过重编程胆碱代谢促进乳腺癌发生。

Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

机构信息

Department of Biosciences and Nutrition, Novum, Karolinska Institutet, Huddinge, Sweden.

Department of Circulation and Medical Imaging, MR Core Facility, Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

Cancer Res. 2016 Oct 1;76(19):5634-5646. doi: 10.1158/0008-5472.CAN-15-2910. Epub 2016 Jul 25.

DOI:10.1158/0008-5472.CAN-15-2910
PMID:27457520
Abstract

Estrogen receptor α (ERα) is a key regulator of breast growth and breast cancer development. Here, we report how ERα impacts these processes by reprogramming metabolism in malignant breast cells. We employed an integrated approach, combining genome-wide mapping of chromatin-bound ERα with estrogen-induced transcript and metabolic profiling, to demonstrate that ERα reprograms metabolism upon estrogen stimulation, including changes in aerobic glycolysis, nucleotide and amino acid synthesis, and choline (Cho) metabolism. Cho phosphotransferase CHPT1, identified as a direct ERα-regulated gene, was required for estrogen-induced effects on Cho metabolism, including increased phosphatidylcholine synthesis. CHPT1 silencing inhibited anchorage-independent growth and cell proliferation, also suppressing early-stage metastasis of tamoxifen-resistant breast cancer cells in a zebrafish xenograft model. Our results showed that ERα promotes metabolic alterations in breast cancer cells mediated by its target CHPT1, which this study implicates as a candidate therapeutic target. Cancer Res; 76(19); 5634-46. ©2016 AACR.

摘要

雌激素受体 α(ERα)是乳腺生长和乳腺癌发展的关键调节因子。在这里,我们报告 ERα 如何通过重新编程恶性乳腺细胞中的代谢来影响这些过程。我们采用了一种综合方法,将染色质结合的 ERα 的全基因组作图与雌激素诱导的转录和代谢谱相结合,证明 ERα 在雌激素刺激下重新编程代谢,包括有氧糖酵解、核苷酸和氨基酸合成以及胆碱(Cho)代谢的变化。Cho 磷酸转移酶 CHPT1 被确定为直接受 ERα 调控的基因,它是雌激素诱导的 Cho 代谢变化所必需的,包括增加磷酸胆碱的合成。CHPT1 沉默抑制了锚定非依赖性生长和细胞增殖,也抑制了他莫昔芬耐药乳腺癌细胞在斑马鱼异种移植模型中的早期转移。我们的研究结果表明,ERα 通过其靶基因 CHPT1 促进乳腺癌细胞中的代谢改变,该研究将 CHPT1 作为候选治疗靶点。Cancer Res; 76(19); 5634-46. ©2016 AACR.

相似文献

1
Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.雌激素受体α通过重编程胆碱代谢促进乳腺癌发生。
Cancer Res. 2016 Oct 1;76(19):5634-5646. doi: 10.1158/0008-5472.CAN-15-2910. Epub 2016 Jul 25.
2
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.重新编程 ERRα 和 ERα 靶基因谱可引发乳腺癌对他莫昔芬的耐药性。
Cancer Res. 2015 Feb 15;75(4):720-31. doi: 10.1158/0008-5472.CAN-14-0652. Epub 2015 Feb 2.
3
Loss of Estrogen-Regulated at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer.雌激素调节基因 at 3p21.1 的缺失促进乳腺癌对他莫昔芬的耐药性。
Cancer Res. 2018 Sep 1;78(17):4915-4928. doi: 10.1158/0008-5472.CAN-18-0069. Epub 2018 Jun 26.
4
Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.抑制刺猬信号通路可下调乳腺癌细胞中的雌激素受体α信号。
Oncotarget. 2016 Nov 1;7(44):71580-71593. doi: 10.18632/oncotarget.12259.
5
Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.Menin 是 MENI 基因的产物,与雌激素受体结合以增强其在乳腺癌细胞中的活性:一种新的他莫昔芬耐药预测因子的可能性。
Breast Cancer Res Treat. 2010 Jul;122(2):395-407. doi: 10.1007/s10549-009-0581-0. Epub 2009 Oct 22.
6
Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.二甲双胍对雌激素受体阳性及他莫昔芬耐药乳腺癌细胞系的抗癌作用。
Oncol Rep. 2016 May;35(5):2553-60. doi: 10.3892/or.2016.4675. Epub 2016 Mar 11.
7
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.雌激素受体α 特异性自身抗体参与激素受体阳性乳腺癌的他莫昔芬耐药。
Cells. 2019 Jul 19;8(7):750. doi: 10.3390/cells8070750.
8
Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.抗雌激素木豆素芪酸对乳腺癌的作用
J Nutr Biochem. 2015 Nov;26(11):1273-82. doi: 10.1016/j.jnutbio.2015.06.004. Epub 2015 Jul 22.
9
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.他莫昔芬与c-Src抑制在预防雌激素受体阳性人乳腺癌细胞生长中的协同作用。
Mol Cancer Ther. 2006 Dec;5(12):3023-31. doi: 10.1158/1535-7163.MCT-06-0394.
10
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.在乳腺癌模型中,内分泌治疗耐药可能与高雌激素受体α(ERα)表达及ERα磷酸化减少有关。
Endocr Relat Cancer. 2006 Dec;13(4):1121-33. doi: 10.1677/erc.1.01257.

引用本文的文献

1
SREBP1-Dependent Metabolism as a Potential Target for Breast Cancer Risk Reduction.作为降低乳腺癌风险潜在靶点的固醇调节元件结合蛋白1(SREBP1)依赖性代谢
Cancers (Basel). 2025 May 14;17(10):1664. doi: 10.3390/cancers17101664.
2
ZNF32 histidine 179 and 183 single-site and double-site mutations promote nuclear speckle formation but differentially regulate the proliferation of breast cancer cells.锌指蛋白32(ZNF32)组氨酸179和183位点的单点及双点突变促进核斑点形成,但对乳腺癌细胞的增殖有不同调控作用。
Front Cell Dev Biol. 2025 Feb 19;13:1490231. doi: 10.3389/fcell.2025.1490231. eCollection 2025.
3
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach.
通过混合配体/基于结构的方法进行雌激素受体阳性乳腺癌双雌激素受体和热休克蛋白90抑制剂的计算机辅助设计
Molecules. 2024 Dec 21;29(24):6040. doi: 10.3390/molecules29246040.
4
Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer.总胆碱在体内质子磁共振波谱分析中对激素受体阳性、HER2阴性早期乳腺癌患者晚期复发预测的预后意义
PLoS One. 2025 Jan 2;20(1):e0311012. doi: 10.1371/journal.pone.0311012. eCollection 2025.
5
Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways.慢性神经性疼痛的临床指标与肯尼迪通路和内源性大麻素通路相关。
Eur J Clin Invest. 2025 Feb;55(2):e14351. doi: 10.1111/eci.14351. Epub 2024 Nov 15.
6
Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.线粒体相关基因作为乳腺癌的预后和转移标志物:综合分析和临床模型的见解。
Front Immunol. 2024 Sep 24;15:1461489. doi: 10.3389/fimmu.2024.1461489. eCollection 2024.
7
ASCT2 is a major contributor to serine uptake in cancer cells.ASCT2 是癌细胞中丝氨酸摄取的主要贡献者。
Cell Rep. 2024 Aug 27;43(8):114552. doi: 10.1016/j.celrep.2024.114552. Epub 2024 Jul 27.
8
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program.雌激素受体转录程序中增强子序列的机制分析。
Commun Biol. 2024 Jun 11;7(1):719. doi: 10.1038/s42003-024-06400-5.
9
ASCT2 is the primary serine transporter in cancer cells.ASCT2是癌细胞中的主要丝氨酸转运体。
bioRxiv. 2023 Oct 11:2023.10.09.561530. doi: 10.1101/2023.10.09.561530.
10
The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications.乳腺癌的代谢格局及其治疗意义。
Mol Diagn Ther. 2023 May;27(3):349-369. doi: 10.1007/s40291-023-00645-2. Epub 2023 Mar 29.